World Cancer Day, Februrary 4, 2021
Everyday, but most especially today, World Cancer Day, the ACSR stands up to cancer. Together, all of our actions matter and the ACSR recommits to supporting our cancer warriors in …
Everyday, but most especially today, World Cancer Day, the ACSR stands up to cancer. Together, all of our actions matter and the ACSR recommits to supporting our cancer warriors in …
Congratulations to the ACSR’s Dr. Alanna Maguire whose work was featured in a NanoString Technologies, Inc. webinar showcasing how Rosalind® was used to identify novel markers and potential therapeutic targets …
Using ACSR Specimens, Colm Keane et al. give us the largest in-depth description of the biology of Primary Central Nervous Lymphoma occurring in patients with AIDS. This disease demonstrates a …
The AACR Annual Meeting 2021 will be presented over two separate weeks: April 10-15, 2021May 17-21, 2021 Registration includes access to both weeks and on-demand access to all sessions through …
Congratulations to ACSR Technology Core Principal Investigator, Dr. Lisa Rimsza, one of three newly elected Lymphoma Research Foundation Scientific Advisory Board Members! Meet the LRF Scientific Advisory Board Members here: …
amfAR’s “Meet the Scientists” discussion, featured some fascinating research by ACSR collaborator, Dr. Tim Schacker! Watch the playback below if you missed it! Click here to watch: amfAR’s Meet the Scientists …
Please join the Office of AIDS Research (OAR) for the NIH World AIDS Day Observance Tuesday, December 1, 2020, from 11:00 a.m. to 12:30 p.m. EST. This virtual event is …
• Letter of Intent required by December 30, 2020• Proposals must be submitted via e-mail in PDF or MS Word by 5 PM EST, Friday, January 29, 2021 to ssilver@gwu.edu. …
The National Cancer Institute (NCI) and Cancer Research UK (CRUK), the world’s leading funders of cancer research, are partnering to fund the Cancer Grand Challenges (CGC) program. Cancer Grand Challenges …
FOA Number: RFA-CA-20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance …